Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: CODON

Market Cap 7L 8L 6L 6L 10.65L 7.11Cr 10.73L 72.26L 28.12L 3.5Cr 28.25L 27.63L 12Cr P/E 2021
-4.36x
P/E 2022 -0.3x
Enterprise Value 15.84L 18.13L 14.66L 13.68L 25.68L 17Cr 25.87L 1.74Cr 67.76L 8.42Cr 68.08L 66.6L 29Cr EV / Sales 2021
3.94x
EV / Sales 2022 1.09x
Free-Float
35.8%
Yield 2021 *
-
Yield 2022 -
Manager TitleAgeSince
Chief Executive Officer 62 16/01/2020
Investor Relations Contact - -
Director TitleAgeSince
Chairman - 29/04/2022
Director/Board Member - 07/07/2010
Director/Board Member 82 12/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.42%+0.06%+20.16%-21.35% 6.21TCr
-0.84%-9.93%+57.21%+194.41% 5.45TCr
-5.75%+29.50%+29.50%+29.50% 4.15TCr
-2.96%+4.99%-53.01%-60.20% 3.91TCr
+1.59%-0.17%+57.20%-32.15% 2.9TCr
-7.22%+18.90%+129.13%-50.98% 2.54TCr
+5.54%-4.49%+51.42%+67.49% 1.96TCr
-1.05%-1.44%-3.02%+139.59% 1.69TCr
+1.04%+1.28%+63.17%+110.01% 1.59TCr
Average -0.88%+2.11%+39.08%+41.81% 3.38TCr
Weighted average by Cap. -1.22%+0.90%+34.29%+37.34%

Financials

2021 2022
Net sales 98.03L 1.12Cr 90.68L 84.63L 1.59Cr 106.02Cr 1.6Cr 11Cr 4.19Cr 52Cr 4.21Cr 4.12Cr 181.08Cr 62.41L 71.43L 57.73L 53.88L 1.01Cr 67Cr 1.02Cr 6.86Cr 2.67Cr 33Cr 2.68Cr 2.62Cr 115.29Cr
Net income -93.22L -1.07Cr -86.23L -80.48L -1.51Cr -100.82Cr -1.52Cr -10Cr -3.99Cr -50Cr -4.01Cr -3.92Cr -172.2Cr -1.7Cr -1.94Cr -1.57Cr -1.47Cr -2.75Cr -183.64Cr -2.77Cr -19Cr -7.26Cr -90Cr -7.3Cr -7.14Cr -313.66Cr
Net Debt -3L -3L -3L -3L -5L -3.17Cr -5L -32.21L -12.53L -1.56Cr -12.59L -12.32L -5.41Cr 9L 10.61L 9L 8L 15.02L 10Cr 15.13L 1.02Cr 39.65L 4.93Cr 39.83L 38.97L 17Cr
Logo CODON
CoDon AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company develops, produces, and distributes autologous cell therapies for the minimally invasive repair of cartilage defects, it manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures, and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. It also offers biopsy, cultivation, transplantation, rehabilitation and others.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!